Timothy J. Barberich, Director at TScan Therapeutics, Inc. (TCRX), bought 75,760 shares at $2.63 ($199K) on 2023-06-02, disclosed to the SEC on 2023-06-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.63 | 37,880 | $100K | 50.0% |
| 2 | $2.63 | 37,880 | $100K | 50.0% |
| Total | $2.63 avg | 75,760 | $199K | 100% |
| Filing → |
| VSTM | BUY | 2019-03-19 | $106K | — | Filing → |
| VSTM | BUY | 2018-10-02 | $37K | — | Filing → |
| VSTM | BUY | 2017-12-07 | $478K | — | Filing → |